Prioritised investments from pharma companies shaping competitive pipeline landscape of…
In recent years, bronchiectasis has garnered a significant amount of attention, with pharmaceutical companies prioritising their…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Insmed
Anticipation builds as Insmed bronchiectasis therapy brensocatib nears Phase III completion:…
Brensocatib is a dipeptidyl peptidase-1 (DPP-1) reversible inhibitor which exhibits anti-inflammatory action through suppressing…